eHealth Market– Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is a.
Pancreatic cancer is the seventh leading cause of cancer death worldwide and despite the increasing incidence of this disease, effective treatments are lacking and prognosis for patients with this tumor type remains poor, with approximately 70% of patients dying within one year of diagnosis.
ACT-Discover Liquid Biopsy Boosts Tumor DNA Detection by 30% miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
BIRMINGHAM, Ala. and Pensacola, Fla. (PRWEB) May 11, 2023 CIRCULOGENE is an innovative medical technology company transforming precision medicine through
Gurgaon (Haryana) [India], March 14 (ANI/BusinessWire India): Art of Healing Cancer, a leading cancer care provider in India, is pleased to share information on the role of liquid biopsy in the management of cancer. This technique is revolutionizing cancer care by providing a non-invasive and more accurate way of detecting cancer and monitoring its progression. Liquid Biopsy in layman's terms is detecting cancer cells or cancer material from a simple blood sample rather than putting needles in the body organs to get tissues/cells for assessment of cancer cells. Dr Mandeep Singh, Chief mentor & Lead oncologist at Art of Healing Cancer, explains Liquid Biopsy is either in form of Circulating tumor DNA (CtDNA) i.e. genetic material that is released by tumor cells into the bloodstream, while Circulating Tumor Cells (CTCs) are whole tumor cells that have detached from the primary tumor and entered the bloodstream. It is a less invasive and simpler procedure. It has a proven role in